Marco Onofrj Selected Research

CB 3717

6/2010

Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Onofrj Research Topics

Disease

27	Parkinson Disease (Parkinson's Disease) 12/2020 - 03/2003
14	Multiple Sclerosis 01/2022 - 01/2010
14	Dementia (Dementias) 01/2022 - 09/2003
11	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2002
8	Parkinsonian Disorders (Parkinsonism) 08/2015 - 11/2003
7	Relapsing-Remitting Multiple Sclerosis 12/2021 - 01/2019
6	Hallucinations (Hallucination) 01/2020 - 03/2003
4	Cognitive Dysfunction 02/2022 - 01/2015
4	Inflammation (Inflammations) 01/2021 - 11/2012
3	COVID-19 05/2022 - 04/2021
3	Medically Unexplained Symptoms 02/2022 - 01/2019
3	Delirium 01/2022 - 04/2021
3	Neuroinflammatory Diseases 10/2021 - 01/2019
3	Stroke (Strokes) 07/2020 - 11/2019
3	Dystonia (Limb Dystonia) 10/2016 - 10/2007
3	Seizures (Absence Seizure) 10/2016 - 01/2014
3	Hyperthermia 07/2015 - 12/2005
3	Gambling (Pathological Gambling) 01/2014 - 09/2010
3	Tremor (Tremors) 07/2013 - 08/2007
3	Dyskinesias (Dyskinesia) 03/2011 - 12/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022 - 01/2019
2	Headache (Headaches) 05/2022 - 02/2022
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 11/2011
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 03/2016
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2021 - 01/2014
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 07/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2011
2	Epilepsy (Aura) 01/2021 - 06/2008
2	Psychotic Disorders (Schizoaffective Disorder) 12/2020 - 12/2007
2	Meningitis 01/2019 - 10/2016
2	Synucleinopathies 01/2019 - 07/2011
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2010
2	Guillain-Barre Syndrome 05/2015 - 12/2009
2	Polyneuropathies (Polyneuropathy) 05/2015 - 12/2009
2	Deglutition Disorders (Dysphagia) 02/2014 - 12/2009
2	Anhedonia 07/2013 - 08/2012
2	Major Depressive Disorder (Major Depressive Disorders) 01/2013 - 08/2012
2	Lewy Body Disease (Lewy Body Dementia) 11/2012 - 11/2003
2	Nausea 03/2011 - 05/2007
1	Temporal Lobe Epilepsy 07/2022
1	Pain (Aches) 05/2022
1	Thrombosis (Thrombus) 05/2022
1	Thrombocytopenia (Thrombopenia) 05/2022
1	Conversion Disorder (Astasia Abasia) 02/2022
1	Migraine Disorders (Migraine) 02/2022
1	Migraine without Aura (Common Migraine) 02/2022
1	Sudden Unexpected Death in Epilepsy 01/2022
1	Mental Disorders (Mental Disorder) 10/2021
1	Disease Progression 09/2021

Drug/Important Bio-Agent (IBA)

12	Levodopa (L Dopa)FDA LinkGeneric 02/2022 - 07/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
5	Pharmaceutical PreparationsIBA 07/2022 - 04/2005
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 11/2012
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2009
5	Antipsychotic Agents (Antipsychotics)IBA 10/2016 - 12/2005
4	Cholinergic Agents (Cholinergics)IBA 01/2022 - 07/2008
4	Fingolimod Hydrochloride (FTY720)FDA Link 11/2021 - 01/2019
4	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 07/2008
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2008 - 07/2002
3	AntibodiesIBA 05/2022 - 01/2021
3	Natalizumab (Tysabri)FDA Link 11/2021 - 04/2021
3	Dimethyl FumarateIBA 04/2021 - 01/2019
3	alpha-SynucleinIBA 08/2015 - 07/2011
3	EnzymesIBA 07/2015 - 12/2009
3	Amantadine (Aman)FDA LinkGeneric 01/2014 - 09/2010
3	Donepezil (Aricept)FDA LinkGeneric 07/2008 - 07/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 07/2008 - 07/2003
2	perampanelIBA 07/2022 - 05/2010
2	VaccinesIBA 05/2022 - 02/2022
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2022 - 01/2019
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 01/2014
2	SteroidsIBA 09/2020 - 07/2015
2	Alemtuzumab (Campath)FDA Link 04/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 02/2020 - 01/2018
2	LipidsIBA 01/2019 - 11/2011
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2016 - 07/2008
2	Olanzapine (Zyprexa)FDA Link 03/2016 - 01/2011
2	Clozapine (Clozaril)FDA LinkGeneric 03/2016 - 12/2007
2	SynucleinsIBA 08/2015 - 07/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 08/2012
2	agomelatine (S20098)IBA 01/2013 - 08/2012
2	safinamideIBA 01/2012 - 07/2008
2	Vitamin E FDA LinkGeneric 07/2008 - 07/2002
2	Rivastigmine (Exelon)FDA LinkGeneric 05/2007 - 04/2006
1	Ad26COVS1IBA 05/2022
1	Platelet Factor 4IBA 05/2022
1	Vitamin K FDA Link 05/2022
1	Heparin (Liquaemin)FDA LinkGeneric 05/2022
1	BNT162 VaccineIBA 02/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	TabletsIBA 01/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	Cladribine FDA LinkGeneric 01/2022
1	thiocolchicosideIBA 01/2022
1	ElementsIBA 10/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021

Therapy/Procedure

15	Therapeutics 12/2021 - 07/2003
2	Immunotherapy 01/2020 - 01/2019
1	Spinal Injections 01/2022
1	Precision Medicine 09/2021